Sunday, July 19

● Latest

Sports Spain Beat Argentina in Extra Time to Win Second World Cup Technology The 630-Mile Texas Race Where the Only Fuel Is Sunlight Culture Nolan's The Odyssey Opens to 124.5 Million in North America World US and Iran Edge Toward Wider War as Third Service Member Is Killed Politics Burnham Signals North Sea Shift as He Prepares to Take Office World Lebanese food influencer sentenced in absentia to life for hashish smuggling World Syria replaces its security and intelligence chiefs after two bombings Sports Ryan Fox birdies the last to win The Open by one Sports Spain Beat Argentina in Extra Time to Win Second World Cup Technology The 630-Mile Texas Race Where the Only Fuel Is Sunlight Culture Nolan's The Odyssey Opens to 124.5 Million in North America World US and Iran Edge Toward Wider War as Third Service Member Is Killed Politics Burnham Signals North Sea Shift as He Prepares to Take Office World Lebanese food influencer sentenced in absentia to life for hashish smuggling World Syria replaces its security and intelligence chiefs after two bombings Sports Ryan Fox birdies the last to win The Open by one

Topic: clinical-evidence

An Ozempic injection pen, one of the GLP-1 receptor agonist medications

Sunday, 7/19, 10:46 AM

GLP-1 drugs are reaching older patients faster than the evidence about them

Roughly one in ten participants in the early trials of these weight-loss and diabetes drugs was over 65.
As prescribing expands to older adults, researchers say the specific risks for that group, from muscle loss to falls, are not well characterized.

clinical-evidence — news and stories on this topic

This page collects all of Newsparlor's coverage of clinical-evidence. Follow the topic from one place: new stories appear here automatically as more is published. That way you stay on top of how the situation develops.

Looking for the bigger picture? Browse world news, business news, sport and politics, or head back to the front page for the day's top stories.